NCT01119950 - Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

388

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

NVA237 12.5 µg once daily

NVA237 12.5 µg via dry powder inhaler once daily for 28 days during either period 1 or during period 2.

DRUG

NVA237 25.0 µg once daily

NVA237 25.0 µg via dry powder inhaler once daily for 28 days during either period 1 or during period 2.

DRUG

NVA237 12.5 µg twice daily

NVA237 12.5 µg via dry powder inhaler twice daily for 28 days during either period 1 or during period 2.

DRUG

NVA237 50.0 µg once daily

NVA237 50.0 µg via dry powder inhaler once daily for 28 days during either period 1 or during period 2.

DRUG

NVA237 25.0 µg twice daily

NVA237 25.0 µg via dry powder inhaler twice daily for 28 days during either period 1 or during period 2.

DRUG

NVA237 100.0 µg once daily

NVA237 100.0 µg via dry powder inhaler once daily for 28 days during either period 1 or during period 2.

DRUG

NVA237 50.0 µg twice daily

NVA237 50.0 µg via dry powder inhaler twice daily for 28 days during either period 1 or during period 2.

DRUG

Placebo to NVA237 once daily

Placebo to NVA237 via dry powder inhaler once daily for 28 days during either period 1 or during period 2.

Trial Locations (29)

19102

Novartis Investigative Site, Philadelphia

36201

Novartis Investigative Site, Anniston

68104

Novartis Investigative Site, Omaha

80012

Novartis Investigative Site, Denver

90501

Novartis Investigative Site, Torrance

92101

Novartis Investigative Site, San Diego

Unknown

Novartis Investigative Site, Antwerp

Novartis Investigative Site, Genk

Novartis Investigative site, Jambes

Novartis Investigative Site, München

Novartis Investigative Site, Balassagyarmat

Novartis Investigative Site, Balatonfüred

Novartis Investigative Site, Budapest

Novartis Investigative Site, Debrecen

Novartis Investigative Site, Szolnok

Novartis Investigative Site, Törökbálint

Novartis Investigative Site, Almelo

Novartis Investigative Site, Eindhoven

Novartis Investigative Site, Harderwijk

Novartis Investigative Site, Heerlen

Novartis Investigative Site, Helmond

Novartis Investigative Site, Veldhoven

Novartis Investigative Site, Zutphen

Novartis Investigative Site, Izabelin

Novartis Investigative Site, Lodz

Novartis Investigative Site, Warsaw

Novartis Investigative Site, A Coruña

Novartis Investigative Site, Alicante

Novartis Investigative Site, Ponferrada